Literature DB >> 6965606

Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.

T Han, J Minowada, V Subramanian, M Barcos, U Kim.   

Abstract

The splenic T and B cell distribution in 79 patients with untreated Hodgkin's disease was quite similar to that in 15 control patients with non-Hodgkin's lymphoma or carcinoma. The mean T lymphocyte percentage was slightly higher in involved spleens than in uninvolved spleens of patients with Hodgkin's disease. There was no significant difference in the T and B cell distribution between tumor area and tumor-free area of the same spleens of Hodgkin's disease patients. Splenic T and B cell distribution did not correlate well with the clinical features of Hodgkin's disease. The splenic T cell percentage was significantly lower than that of the peripheral blood T cell percentage (P less than 0.05), while the splenic B cell percentage was significantly higher than peripheral blood B cell percentage (P less than 0.01) in 13 patients with untreated Hodgkin's disease. The splenic T lymphocyte response to PHA was significantly higher than the peripheral blood T lymphocyte response (P less than 0.05), and the splenic B lymphocyte response to PHA, in the presence of irradiated autologous splenic T lymphocytes, was also significantly higher than the peripheral blood B lymphocyte response (P less than 0.05) in 8 and 6 patients with untreated Hodgkin's disease, respectively. Since the control splenic cells, utilized in this study were obtained not from patients with non-neoplastic disease, but from patients with neoplastic disease other than Hodgkin's disease, our data are not conclusive, but only suggestive of normal T and B cell distribution and function in uninvolved spleens of patients with untreated Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965606     DOI: 10.1002/1097-0142(19800215)45:4<767::aid-cncr2820450426>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Cell-mediated cytotoxic activity of spleen cells from patients with gastric carcinoma.

Authors:  T Akiyoshi; F Koba; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1988-03

2.  Effect of arginase on splenic killer cell activity in patients with gastric cancer.

Authors:  C W Wu; C W Chi; C K Ho; S L Chien; W Y Liu; F K P'eng; S R Wang
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

Review 3.  The role of the spleen in leukemias and lymphomas including Hodgkin's disease.

Authors:  R Maurer
Journal:  Experientia       Date:  1985-02-15

4.  Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-Hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies.

Authors:  F Herrmann; G Sieber; B Jauer; A Lochner; B Komischke; H Rühl
Journal:  Blut       Date:  1983-07

5.  Impaired B-lymphocyte reactivity in patients with Hodgkin's disease and non-Hodgkin-lymphomas.

Authors:  H Rühl; B Enders; M Bur; G Sieber
Journal:  Blut       Date:  1981-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.